BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17546041)

  • 1. Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis.
    Capel E; Fléjou JF; Hamelin R
    Oncogene; 2007 Nov; 26(54):7596-600. PubMed ID: 17546041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.
    Poynter JN; Siegmund KD; Weisenberger DJ; Long TI; Thibodeau SN; Lindor N; Young J; Jenkins MA; Hopper JL; Baron JA; Buchanan D; Casey G; Levine AJ; Le Marchand L; Gallinger S; Bapat B; Potter JD; Newcomb PA; Haile RW; Laird PW;
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3208-15. PubMed ID: 18990764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of microsatellite instability, MLH1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas among Tunisians patients.
    Kria Ben Mahmoud L; Arfaoui A; Khiari M; Chaar I; Lounis A; Sammoud S; Ben Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
    Tunis Med; 2012; 90(8-9):646-53. PubMed ID: 22987381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.
    Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K
    BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
    Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
    Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers.
    Furukawa T; Konishi F; Masubuchi S; Shitoh K; Nagai H; Tsukamoto T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):1-10. PubMed ID: 12203784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer.
    Menigatti M; Di Gregorio C; Borghi F; Sala E; Scarselli A; Pedroni M; Foroni M; Benatti P; Roncucci L; Ponz de Leon M; Percesepe A
    Genes Chromosomes Cancer; 2001 Aug; 31(4):357-61. PubMed ID: 11433526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC.
    Morak M; Schackert HK; Rahner N; Betz B; Ebert M; Walldorf C; Royer-Pokora B; Schulmann K; von Knebel-Doeberitz M; Dietmaier W; Keller G; Kerker B; Leitner G; Holinski-Feder E
    Eur J Hum Genet; 2008 Jul; 16(7):804-11. PubMed ID: 18301449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.
    Rahner N; Friedrichs N; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
    J Pathol; 2008 Jan; 214(1):10-6. PubMed ID: 17973250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer.
    Mrkonjic M; Roslin NM; Greenwood CM; Raptis S; Pollett A; Laird PW; Pethe VV; Chiang T; Daftary D; Dicks E; Thibodeau SN; Gallinger S; Parfrey PS; Younghusband HB; Potter JD; Hudson TJ; McLaughlin JR; Green RC; Zanke BW; Newcomb PA; Paterson AD; Bapat B
    PLoS One; 2010 Oct; 5(10):e13314. PubMed ID: 20967208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
    Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
    Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLH1 promoter methylation, diet, and lifestyle factors in mismatch repair deficient colorectal cancer patients from EPIC-Norfolk.
    Gay LJ; Arends MJ; Mitrou PN; Bowman R; Ibrahim AE; Happerfield L; Luben R; McTaggart A; Ball RY; Rodwell SA
    Nutr Cancer; 2011; 63(7):1000-10. PubMed ID: 21875327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations in mismatch repair genes in sporadic gastric carcinomas are not a cause but a consequence of the mutator phenotype.
    Pinto M; Wu Y; Mensink RG; Cirnes L; Seruca R; Hofstra RM
    Cancer Genet Cytogenet; 2008 Jan; 180(2):110-4. PubMed ID: 18206535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
    Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
    Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
    Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer.
    Valle L; Carbonell P; Fernandez V; Dotor AM; Sanz M; Benitez J; Urioste M
    Clin Genet; 2007 Mar; 71(3):232-7. PubMed ID: 17309645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis.
    Miyakura Y; Sugano K; Konishi F; Fukayama N; Igarashi S; Kotake K; Matsui T; Koyama Y; Maekawa M; Nagai H
    Genes Chromosomes Cancer; 2003 Jan; 36(1):17-25. PubMed ID: 12461746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry.
    Levine AJ; Win AK; Buchanan DD; Jenkins MA; Baron JA; Young JP; Long TI; Weisenberger DJ; Laird PW; McCall RL; Duggan DJ; Haile RW
    Cancer Prev Res (Phila); 2012 Feb; 5(2):328-35. PubMed ID: 22144422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.